Tumor necrosis factor-alpha blocker in treatment of juvenile idiopathic arthritis-associated uveitis refractory to second-line agents: results of a multinational survey. [electronic resource]
Producer: 20070622Description: 1146-50 p. digitalISSN:- 0315-162X
- Adalimumab
- Adolescent
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized
- Arthritis, Juvenile -- complications
- Child
- Cohort Studies
- Cross-Sectional Studies
- Drug Resistance
- Etanercept
- Glucocorticoids -- therapeutic use
- Humans
- Immunoglobulin G -- therapeutic use
- Infliximab
- International Cooperation
- Receptors, Tumor Necrosis Factor -- therapeutic use
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
- Uveitis -- drug therapy
No physical items for this record
Publication Type: Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.